المؤلفون: Neil A. Accortt, Eunice Chang, Michael S. Broder, Elya Papoyan, Jennifer Schenfeld

المصدر: Advances in Therapy

مصطلحات موضوعية: Drug Utilization, musculoskeletal diseases, Adult, Male, medicine.medical_specialty, Etanercept, Arthritis, Rheumatoid, 03 medical and health sciences, Insurance Claim Review, 0302 clinical medicine, McNemar's test, Pharmacotherapy, Rheumatology, Internal medicine, medicine, Drug utilization, Humans, Pharmacology (medical), 030212 general & internal medicine, Rheumatoid arthritis, Original Research, Aged, Retrospective Studies, 030203 arthritis & rheumatology, business.industry, Healthcare, Anti-Inflammatory Agents, Non-Steroidal, Retrospective cohort study, General Medicine, Emergency department, Middle Aged, medicine.disease, Treatment Outcome, Antirheumatic Agents, Physical therapy, Administrative claims, Female, business, Delivery of Health Care, medicine.drug, Compliance

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ca5bc920dc2d67809ceec1d0b7102fTest
http://europepmc.org/articles/PMC5599457Test

المؤلفون: Juan Manuel Bello-Gualtero, D. Gomez, Carlos Castro, Pedro Santos-Moreno, Guillermo Sánchez

المصدر: Journal of Clinical Rheumatology

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Tumor Necrosis Factor-alpha and Comparative Effectiveness Research, Etanercept, Arthritis, Rheumatoid, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Rheumatology, Internal medicine, medicine, Adalimumab, Humans, 030212 general & internal medicine, Adverse effect, skin and connective tissue diseases, Retrospective Studies, 030203 arthritis & rheumatology, business.industry, Tumor Necrosis Factor-alpha, drug-related side effects and adverse reactions in this cohort, Retrospective cohort study, Original Articles, Middle Aged, medicine.disease, Infliximab, Antirheumatic Agents, Clinical trial, Treatment Outcome, arthritis, Rheumatoid arthritis, Physical therapy, business, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de7251208e0590bf5904ce8989e70570Test
http://europepmc.org/articles/PMC4927323Test

المؤلفون: Małgorzata Kwiatkowska, Ewa Jednacz, Lidia Rutkowska-Sak

المصدر: Rheumatology, Vol 53, Iss 3, Pp 157-160 (2015)
Reumatologia

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Cyclophosphamide, Immunology, Arthritis, lcsh:Medicine, Case Reports, Etanercept, chemistry.chemical_compound, tocilizumab, Tocilizumab, Rheumatology, medicine, Immunology and Allergy, amyloidosis, Chlorambucil, business.industry, Amyloidosis, lcsh:R, medicine.disease, Dermatology, chemistry, Physical therapy, Prednisolone, juvenile idiopathic arthritis, business, Nephrotic syndrome, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7827aead8d0ec297a3b43903ef98bd0Test
http://www.termedia.pl/Case-reports-Juvenile-idiopathic-arthritis-complicated-by-amyloidosis-with-secondary-nephrotic-syndrome-effective-treatment-with-tocilizumab,18,25553,1,1.htmlTest

المؤلفون: Slobodan M. Jankovic

المصدر: Racionalna Terapija, Vol 5, Iss 1, Pp 1-7 (2013)

مصطلحات موضوعية: Drug, musculoskeletal diseases, rheumatoid arthritis, medicine.medical_specialty, Environmental Engineering, media_common.quotation_subject, Arthritis, Industrial and Manufacturing Engineering, Etanercept, Pharmacoeconomics, rituximab, pharmacoeconomics, Internal medicine, medicine, Health insurance, budget impact analysis, health care economics and organizations, media_common, lcsh:R5-920, business.industry, Drug budget, medicine.disease, Rheumatoid arthritis, Physical therapy, Rituximab, business, lcsh:Medicine (General), etanercept, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c0e75ae72b0f3a8fc544abffd731987Test
http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2013/1821-05381301001J.pdfTest

المؤلفون: Kirk Barber, Melanie Poulin-Costello, Robert Bissonnette, Marc Bourcier, C Lynde, Jack Toole, Yves Poulin, Kim A. Papp, J. Shelton, K. Garces

المصدر: Journal of the European Academy of Dermatology and Venereology

مصطلحات موضوعية: musculoskeletal diseases, Male, medicine.medical_specialty, Topical Corticosteroid Therapy, Administration, Topical, Dermatology, Etanercept, law.invention, Patient satisfaction, Randomized controlled trial, Quality of life, law, Adrenal Cortex Hormones, Psoriasis, Surveys and Questionnaires, medicine, Humans, skin and connective tissue diseases, business.industry, Maintenance dose, Dermatology Life Quality Index, Original Articles, Middle Aged, medicine.disease, stomatognathic diseases, Infectious Diseases, Treatment Outcome, Patient Satisfaction, Physical therapy, Quality of Life, Original Article, Drug Therapy, Combination, Female, business, Immunosuppressive Agents, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a177e19e6f92f8a5ce0e8b42460c9a30Test
http://europepmc.org/articles/PMC5024053Test

المؤلفون: Orietta Zaniolo, Viola Sacchi, Ignazio Olivieri

المصدر: Farmeconomia: Health Economics and Therapeutic Pathways, Vol 11, Iss 2, Pp 63-76 (2010)

مصطلحات موضوعية: musculoskeletal diseases, psoriatic arthritis, medicine.medical_specialty, Ankylosing spondylitis, lcsh:R5-920, business.industry, medicine.disease, Dermatology, Infliximab, Etanercept, Psoriatic arthritis, ankylosing spondylitis, Physical therapy, Adalimumab, Medicine, Tumor necrosis factor alpha, Reactive arthritis, business, skin and connective tissue diseases, lcsh:Medicine (General), Spondylitis, etanercept, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c9ea24def85290c44ab6cf43d50fe2Test
https://journals.seedmedicalpublishers.com/index.php/FE/article/view/184Test

المؤلفون: R. ten Cate, M. A. J. van Rossum, J.M. van den Berg, L.W.A. van Suijlekom-Smit, P. C. E. Hissink Muller, I. C. J. Brederije, D. M. C. Brinkman, W. P. Bekkering, Y. Koopman-Keemink, Taco W. Kuijpers, D. Schonenberg, Cornelia F Allaart

المساهمون: Pediatrics, AII - Inflammatory diseases, Graduate School, Paediatric Infectious Diseases / Rheumatology / Immunology, ARD - Amsterdam Reproduction and Development, AII - Amsterdam institute for Infection and Immunity, General Paediatrics

المصدر: Pediatric Rheumatology, 15(1). BioMed Central
Pediatric Rheumatology Online Journal
Pediatric Rheumatology
Pediatric Rheumatology, 15:11. BioMed Central Ltd.
Pediatric rheumatology online journal, 15(1). BioMed Central
Pediatric Rheumatology, 15

مصطلحات موضوعية: Male, Arthritis, Administration, Oral, Pediatrics, Treatment strategy study, Etanercept, 0302 clinical medicine, Prednisone, Immunology and Allergy, 030212 general & internal medicine, Child, skin and connective tissue diseases, Drug Substitution, Perinatology, and Child Health, Multicenter Study, Treatment Outcome, Antirheumatic Agents, Child, Preschool, Randomized Controlled Trial, Drug Therapy, Combination, Female, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Combination therapy, Injections, Subcutaneous, Short Report, Biologicals, Drug Administration Schedule, 03 medical and health sciences, Psoriatic arthritis, Rheumatology, Sulfasalazine, Window of opportunity, Internal medicine, medicine, Journal Article, Humans, Comparative Study, Pediatrics, Perinatology, and Child Health, 030203 arthritis & rheumatology, Intention-to-treat analysis, business.industry, Inactive disease, Treat to target, Juvenile idiopathic arthritis, medicine.disease, Arthritis, Juvenile, Methotrexate, Pediatrics, Perinatology and Child Health, Physical therapy, business

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c5877b335547755d27ba8be98b5ca00Test
https://dspace.library.uu.nl/handle/1874/349179Test

المؤلفون: Jean-Luc Schmutz, Denis Jullien, Laurent Misery, Florence Tubach, Caroline Giboin, Sébastien Barbarot, Marie-Aleth Richard, P. Bravard, Elodie Regnier, Hervé Bachelez, Emilie Sbidian, Pascal Joly, Emmanuel Mahé, Nathalie Beneton, Alain Dupuy, Philippe Modiano, Olivier Chosidow, Marie Beylot-Barry, Emmanuel Delaporte, Jean-Philippe Lacour, Carle Paul, Manuelle Viguier

المساهمون: Epidemiology in Dermatology and Evaluation in Therapeutics (EpiDermE), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Centre d'Investigation Clinique Henri Mondor (CIC Henri Mondor), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Henri Mondor-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Hôpital Henri Mondor, CIC Paris Est, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Imagine - Institut des maladies génétiques (IMAGINE - U1163), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Unité différenciation épidermique et auto-immunité rhumatoïde (UDEAR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Physiopathologie du cancer du foie, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Investigation Clinique [Rennes] (CIC), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Hôpital Robert Debré, CRCM, Université Paris7, Assistance Publique - Hôpitaux de Paris, Centre Hospitalier Universitaire de Nice (CHU Nice), Service de neurologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), CHU Le Havre, Hôpital Victor Dupouy, Centre Hospitalier Le Mans (CH Le Mans), Hôpital de la Cavale Blanche - CHRU Brest (CHU - BREST ), CHU Lille, Université de Lille, Hôpital St Vincent de Paul, Centre hospitalier universitaire de Nantes (CHU Nantes), Hôpital de la Croix-Rousse [CHU - HCL], Hospices Civils de Lyon (HCL), CHU Marseille, Physiopathologie, Autoimmunité, maladies Neuromusculaires et THErapies Régénératrices (PANTHER), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris 1 Panthéon-Sorbonne (UP1), Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), French Ministry of Health [PHRC AOM 09 195], French Agency for Drugs (ANSM), Abbvie, Janssen, Pfizer, MSD France, Departement a la Recherche Clinique et au Developpement (DRCD), Assistance Publique-Hopitaux de Paris, Centre d'investigation clinique Paris Est (CIC Paris-Est), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Henri Mondor-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [APHP], Centre National de la Recherche Scientifique (CNRS)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Le MAns, Université Panthéon-Sorbonne (UP1), Centre d'investigation clinique Paris Est [CHU Pitié Salpêtrière] (CIC Paris-Est), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Université de Toulouse (UT)-Université de Toulouse (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Rennes (UR)-Hôpital Pontchaillou-Institut National de la Santé et de la Recherche Médicale (INSERM), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Henri Mondor-Assistance publique - Hôpitaux de Paris (AP-HP) (APHP), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Service de Dermatologie et Allergologie [CHRU Nancy], Service de Dermatologie - Centre Hospitalier Victor Dupouy, Fédération Hospitalière de France, Service de dermatologie (CH Le Mans), CIC Brest, Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital de la Cavale Blanche, Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Service de dermatologie [Nantes], Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes), CHU Cochin [AP-HP], Hôpital de la Timone [CHU - APHM] (TIMONE), AP-HP Hôpital universitaire Robert-Debré [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)

المصدر: Journal of the European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology, Wiley, 2017, 31 (12), pp.2046-2054. ⟨10.1111/jdv.14406⟩
Journal of the European Academy of Dermatology and Venereology, 2017, 31 (12), pp.2046-2054. ⟨10.1111/jdv.14406⟩

مصطلحات موضوعية: Adult, Male, musculoskeletal diseases, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Clinical Decision-Making, Dermatology, Severity of Illness Index, Etanercept, 030207 dermatology & venereal diseases, 03 medical and health sciences, Psoriatic arthritis, 0302 clinical medicine, Internal medicine, Psoriasis, Ustekinumab, Adalimumab, medicine, Humans, Prospective Studies, Prospective cohort study, Biological Products, business.industry, Middle Aged, medicine.disease, Infliximab, 3. Good health, Infectious Diseases, 030220 oncology & carcinogenesis, Cohort, Physical therapy, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, Female, business, [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7328400f9a42b79672e365628f09bd04Test
https://hal-univ-rennes1.archives-ouvertes.fr/hal-01684628Test

المؤلفون: Pekka Lahdenne, NM Wulffraat, Victor Boom, Pierre Quartier, SJ Vastert, Angelo Ravelli, Jordi Anton

المساهمون: Universitat de Barcelona, Children's Hospital, Clinicum, HUS Children and Adolescents

المصدر: PEDIATRIC RHEUMATOLOGY
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Recercat. Dipósit de la Recerca de Catalunya
instname
Pediatric Rheumatology, 13(1), 55. BioMed Central
Pediatric Rheumatology Online Journal
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Dipòsit Digital de la UB
Universidad de Barcelona

مصطلحات موضوعية: SJIA, Complications, ACQUIRED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, CYCLOSPORINE-A, CHILDREN, GUIDELINES, Adolescents, Etanercept, Diagnòstic, 3123 Gynaecology and paediatrics, Adrenal Cortex Hormones, Diagnosis, Immunology and Allergy, Macrophage Activation Syndrome, KILLER-CELL DYSFUNCTION, FOLLISTATIN-LIKE PROTEIN-1, Inflamació, 3. Good health, MAS, Systematic review, Cyclosporine, Drug Therapy, Combination, Immunosuppressive Agents, Research Article, HLH, medicine.drug, musculoskeletal diseases, medicine.medical_specialty, Evidence-based practice, Hemophagocytosis, MEDLINE, Teenagers, Rheumatology, ETANERCEPT, medicine, Humans, Pediatrics, Perinatology, and Child Health, SOLUBLE CD25, Intensive care medicine, Inflammation, Hemophagocytic lymphohistiocytosis, Anakinra, Artritis, INTERLEUKIN-18, business.industry, Arthritis, Systemic, Evidence-based medicine, medicine.disease, Arthritis, Juvenile, RHEUMATOID-ARTHRITIS, Treatment, Macrophage activation syndrome, Pediatrics, Perinatology and Child Health, Physical therapy, business, Biomarkers

وصف الملف: image/pdf; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7a065a593f754b6ba9c83420c0ee2ceTest
https://dspace.library.uu.nl/handle/1874/332724Test

المؤلفون: Amanda Burls, Sue Jowett, Anne Fry-Smith, Paresh Jobanputra, Stirling Bryan, Yen-Fu Chen, Pelham Barton, Wendy K Clark

المصدر: Scopus-Elsevier
Health Technology Assessment, Vol 10, Iss 42 (2006)

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, RZ Other systems of medicine, lcsh:Medical technology, Cost effectiveness, medicine.medical_treatment, Cost-Benefit Analysis, R Medicine (General), Antibodies, Monoclonal, Humanized, Drug Costs, Receptors, Tumor Necrosis Factor, Etanercept, Arthritis, Rheumatoid, Internal medicine, Adalimumab, medicine, Humans, skin and connective tissue diseases, Randomized Controlled Trials as Topic, business.industry, Health Policy, Antibodies, Monoclonal, medicine.disease, Rheumatology, Infliximab, United Kingdom, RM Therapeutics. Pharmacology, TNF inhibitor, Treatment Outcome, lcsh:R855-855.5, Rheumatoid arthritis, Antirheumatic Agents, Immunoglobulin G, Number needed to treat, Physical therapy, Quality-Adjusted Life Years, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da901e56687b2e01ca1a39e3a9dc42eaTest
https://ora.ox.ac.uk/objects/uuid:2b8b4ac6-9107-4215-b3d0-035054bc0978Test